International Journal of Breast Cancer / 2018 / Article / Fig 1

Research Article

CDK9 Expression Shows Role as a Potential Prognostic Biomarker in Breast Cancer Patients Who Fail to Achieve Pathologic Complete Response after Neoadjuvant Chemotherapy

Figure 1

Overall survival. Figure 1 depicts the overall survival curves for patients with CDK9 positive versus CDK9 negative tumors. This shows a statistically nonsignificant difference in survival. However, there is a trend for increased overall survival in the group of patients with positive CDK9.

We are committed to sharing findings related to COVID-19 as quickly and safely as possible. Any author submitting a COVID-19 paper should notify us at to ensure their research is fast-tracked and made available on a preprint server as soon as possible. We will be providing unlimited waivers of publication charges for accepted articles related to COVID-19. Sign up here as a reviewer to help fast-track new submissions.